ResMed
RMD
Performance
About ResMed
ResMed is a healthcare technology company based in Australia that specializes in cloud-connected medical devices and software solutions. They focus on treating chronic conditions such as sleep apnea and COPD, enabling patients to manage their health outside of hospital environments. ResMed's innovative products and platforms are designed to enhance care delivery and improve the quality of life for patients while reducing healthcare costs globally.
Recent News
Walt Disney Company, Unilever and Others Join Supply Chain Excellence Awards APAC 2026 Judging Panel
ŌURA Launches Oura Ring 5: Embedding Live Blood Pressure Signals and GLP-1 Tracking Into Wearable Tech
BE Names Berry as CRO, Promotes Two Others
Ōura Files for IPO Amid Healthcare Push
Ōura to Add Blood Pressure Feature Following FDA Policy Change
The Strategic Integration of Neuromodulation in Sleep Medicine: An Analysis of ResMed’s Acquisition of Noctrix Health
Weekly Wrap: Market Steps Back From the Brink with a Rise
Channel Partnerships as a Pre-M&A Strategy in HealthTech: A Strategic Playbook for European and US Markets
Jim Cramer Says Today’s Market Is Punishing Stocks Harder than 1999
Hartford HealthCare Teams with Cadence to Deploy AI Remote Care for Seniors
Sleep Is the Missing Vital Sign, and Health AI Is Scaling the Consequences
Resmed Completes $340M Noctrix Takeover
ResMed Posts 11% Revenue Rise and 20% Net Income Gain in Q3 2026
Resmed and Oura Are Partnering to Expand Access to Sleep Health Education and Care
Strategic Analysis of the ResMed and Oura Partnership: Bridging Consumer Wearables and Clinical Sleep Medicine
Why Female Sleep Disorders Are Often Misdiagnosed as Depression
Australian HealthTech Market: 2026 State of Play & Outlook to 2028
ResMed Completes Noctrix Health Acquisition, Adding RLS Therapy to Sleep‑health Portfolio